Reference
Rogado J, et al. Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients. European Journal of Cancer 109: 21-27, 22 Jan 2019. Available from: URL: http://doi.org/10.1016/j.ejca.2018.10.014
Rights and permissions
About this article
Cite this article
Anti-PD-1 antibodies: immune-related adverse events and efficacy. Reactions Weekly 1739, 6 (2019). https://doi.org/10.1007/s40278-019-57646-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57646-9